{"id":192022,"date":"2016-11-03T08:21:58","date_gmt":"2016-11-03T12:21:58","guid":{"rendered":"http:\/\/www.rochester.edu\/newscenter\/?p=192022"},"modified":"2025-11-19T07:59:48","modified_gmt":"2025-11-19T12:59:48","slug":"seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia","status":"publish","type":"post","link":"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/","title":{"rendered":"Seed grant enables researchers to try new approach to targeting leukemia"},"content":{"rendered":"

(The first in a series looking at promising research projects being supported by the University Research Award program.)<\/em><\/p>\n

University researchers hope to improve the odds of surviving acute myeloid leukemia (AML) with a promising drug that traces its lineage to a chemical found in magnolias. They will load the drug into nanoparticles that will target the inner recesses of bone marrow where leukemia stem cells lurk.<\/p>\n

Team members Rudi Fasan<\/a><\/strong>, associate professor of chemistry; Danielle Benoit<\/a><\/strong>, associate professor of biomedical engineering; and Benjamin Frisch<\/a><\/strong>, research assistant professor of hematology and oncology, are supported by a $75,000 University Research Award<\/a><\/strong>. The award program is one of several University \u201cseed grants\u201d that help investigators develop preliminary data and proof of concept for promising projects, in hopes of leveraging larger awards from federal agencies or foundations to carry the projects to fruition.<\/p>\n

The low survival\u00a0 rates for AML, especially among older patients, and the limited treatment options when the disease relapses constitute \u201cone of the major challenges in leukemia,\u201d Fasan says. Even after the bulk of active leukemia cells in the bloodstream are destroyed by an initial round of chemotherapy, he says, a \u201cquiescent\u201d subpopulation of leukemia stem cells often survives in the bone marrow.<\/p>\n

When the stem cells enable the cancer to repopulate during a relapse, the newly emerged cancer is often more aggressive and more resistant to treatment.<\/p>\n

\u201cWhat is important is to be able not only t0 target leukemia cells selectively, but also to eradicate cancer stem cells as well,\u201d Fasan says. He believes the researchers and labs collaborating on the project are particularly well suited to take on the challenge, bringing to bear expertise in organic and medicinal chemistry (Fasan), drug delivery technologies (Benoit), and the physiopathology of bone marrow during myeloid malignancy (Frisch).<\/p>\n

For example, Fasan\u2019s lab has worked for several years with chemical compounds extracted from plants, further refining them as anticancer agents. One such compound is micheliolide, derived from a naturally occurring chemical that makes magnolia leaves unpalatable to insects. Using a combination of engineered enzymes and chemical methods, Fasan\u2019s lab has further modified micheliolide to develop analogs \u2013 or variants \u2013 with improved activity against both active leukemia cells and leukemia stem cells.<\/p>\n

\u201cWe can generate entire libraries of this compound,\u201d says Fasan. His team is working with Frisch on testing which analogs are most effective, and at which doses, when applied to an acute myeloid leukemia cell line used in the Frisch lab.<\/p>\n

\"This
An illustration from the Benoit lab shows how it forms nanoparticle drug delivery vehicles. Polymers containing both hydrophilic (water attracting) and hydrophobic (water repelling) portions are synthesized. When the polymers are introduced to a water-based solvent, the particles form nanometer-sized micelles (nanoparticles). Drugs are loaded into the micelles, and targeting moieties selected to target bone marrow are conjugated to the outside, to provide preferential drug delivery to marrow-resident stem cells.<\/figcaption><\/figure>\n

Benoit\u2019s lab, in the meantime, has been developing polymer nanoparticles as vehicles for delivering chemotherapeutic drugs to specific parts of the body where a disease occurs, in order to minimize damage to healthy tissues.<\/p>\n

Her lab recently augmented the nanoparticles with a peptide that can help steer the drug vehicles specifically to bone marrow. The peptide binds to the TRAP enzyme that is released when diseased or worn bone tissue is broken down by osteoclasts during the body\u2019s ongoing process of bone remodeling. The remodeling activity is especially prevalent in the marrow of leukemia patients.<\/p>\n

Preliminary studies show that the nanoparticles accumulate at a significantly higher rate in TRAP-positive bone tissue than other tissues, and can efficiently load and then gradually release a chemical compound similar to the one Fasan\u2019s lab has developed.<\/p>\n

Benoit\u2019s lab will further test how the nanoparticles perform when loaded with analogs of Fasan\u2019s compound, and adjust the nanoparticles accordingly.<\/p>\n

Eventually, the two to three most promising nanoparticle-analog combinations will be tested on mice models that replicate AML in Frisch\u2019s lab.<\/p>\n

\u201cThe nice thing about these preclinical models is that they have well defined leukemia stem cell populations that we know reside in the bone marrow,\u201d Frisch says. \u201cSo it provides a nice way to test the ability of these compounds after being loaded into the nanoparticles to actually target leukemia stem cells within the bone marrow.\u201d<\/p>\n

The award will support graduate students working on the project, and also help offset other costs, such as producing sufficient quantities of the compound analogs, optimization of the nanoparticle delivery system, and the cost of the mice used to model leukemia.<\/p>\n

The program \u201cis a great way to get some seed funding and to develop the preliminary data that will make you more competitive for NIH funding,\u201d Benoit says. Frisch concurs.<\/p>\n

And, as Fasan notes, the award enables three researchers with relevant expertise to work on a project that they would not have been able to pursue on their own. \u201cThe great aspect of this award is the opportunity to combine this expertise around a common interest, and really give this a shot, in terms of trying a new direction and seeing if it can leverage additional support.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"

University researchers hope to improve the odds of surviving acute myeloid leukemia by loading a promising compound into nanoparticles that will target the inner recesses of bone marrow where leukemia stem cells lurk.<\/p>\n","protected":false},"author":286,"featured_media":196522,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[42472,116],"tags":[132,7716,18742,19862,18632,9186,31292,16072],"class_list":["post-192022","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-medicine","category-sci-tech","tag-cancer","tag-danielle-benoit","tag-department-of-biomedical-engineering","tag-department-of-chemistry","tag-hajim-school-of-engineering-and-applied-sciences","tag-research-funding","tag-rudi-fasan","tag-school-of-arts-and-sciences"],"acf":[],"yoast_head":"\nSeed grant enables researchers to try new approach to targeting leukemia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Seed grant enables researchers to try new approach to targeting leukemia\" \/>\n<meta property=\"og:description\" content=\"University researchers hope to improve the odds of surviving acute myeloid leukemia by loading a promising compound into nanoparticles that will target the inner recesses of bone marrow where leukemia stem cells lurk.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/\" \/>\n<meta property=\"og:site_name\" content=\"News Center\" \/>\n<meta property=\"article:published_time\" content=\"2016-11-03T12:21:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-19T12:59:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rochester.edu\/newscenter\/wp-content\/uploads\/2016\/11\/fea-hanan.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Bob Marcotte\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bob Marcotte\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\\\/\"},\"author\":{\"name\":\"Bob Marcotte\",\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/#\\\/schema\\\/person\\\/e0d8d271cd290d592461fa9cefca013b\"},\"headline\":\"Seed grant enables researchers to try new approach to targeting leukemia\",\"datePublished\":\"2016-11-03T12:21:58+00:00\",\"dateModified\":\"2025-11-19T12:59:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\\\/\"},\"wordCount\":871,\"image\":{\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/fea-hanan.jpg\",\"keywords\":[\"cancer\",\"Danielle Benoit\",\"Department of Biomedical Engineering\",\"Department of Chemistry\",\"Hajim School of Engineering and Applied Sciences\",\"research funding\",\"Rudi Fasan\",\"School of Arts and Sciences\"],\"articleSection\":[\"Health & Medicine\",\"Science & Technology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\\\/\",\"url\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\\\/\",\"name\":\"Seed grant enables researchers to try new approach to targeting leukemia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/fea-hanan.jpg\",\"datePublished\":\"2016-11-03T12:21:58+00:00\",\"dateModified\":\"2025-11-19T12:59:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/#\\\/schema\\\/person\\\/e0d8d271cd290d592461fa9cefca013b\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/fea-hanan.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/fea-hanan.jpg\",\"width\":1000,\"height\":600,\"caption\":\"PhD student Hanan Alwaseem, in the lab of Rudi Fasan, associate professor of chemistry, demonstrates how she produces analogs of a new compound the lab has developed as a potential treatment for acute myeloid leukemia. (University photo \\\/ Bob Marcotte)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Seed grant enables researchers to try new approach to targeting leukemia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/#website\",\"url\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/\",\"name\":\"News Center\",\"description\":\"Ä¢¹½´«Ã½\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/#\\\/schema\\\/person\\\/e0d8d271cd290d592461fa9cefca013b\",\"name\":\"Bob Marcotte\",\"url\":\"https:\\\/\\\/www.rochester.edu\\\/newscenter\\\/author\\\/bmarcotte\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Seed grant enables researchers to try new approach to targeting leukemia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/","og_locale":"en_US","og_type":"article","og_title":"Seed grant enables researchers to try new approach to targeting leukemia","og_description":"University researchers hope to improve the odds of surviving acute myeloid leukemia by loading a promising compound into nanoparticles that will target the inner recesses of bone marrow where leukemia stem cells lurk.","og_url":"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/","og_site_name":"News Center","article_published_time":"2016-11-03T12:21:58+00:00","article_modified_time":"2025-11-19T12:59:48+00:00","og_image":[{"url":"https:\/\/www.rochester.edu\/newscenter\/wp-content\/uploads\/2016\/11\/fea-hanan.jpg","width":1000,"height":600,"type":"image\/jpeg"}],"author":"Bob Marcotte","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Bob Marcotte","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/#article","isPartOf":{"@id":"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/"},"author":{"name":"Bob Marcotte","@id":"https:\/\/www.rochester.edu\/newscenter\/#\/schema\/person\/e0d8d271cd290d592461fa9cefca013b"},"headline":"Seed grant enables researchers to try new approach to targeting leukemia","datePublished":"2016-11-03T12:21:58+00:00","dateModified":"2025-11-19T12:59:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/"},"wordCount":871,"image":{"@id":"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rochester.edu\/newscenter\/wp-content\/uploads\/2016\/11\/fea-hanan.jpg","keywords":["cancer","Danielle Benoit","Department of Biomedical Engineering","Department of Chemistry","Hajim School of Engineering and Applied Sciences","research funding","Rudi Fasan","School of Arts and Sciences"],"articleSection":["Health & Medicine","Science & Technology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/","url":"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/","name":"Seed grant enables researchers to try new approach to targeting leukemia","isPartOf":{"@id":"https:\/\/www.rochester.edu\/newscenter\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/#primaryimage"},"image":{"@id":"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rochester.edu\/newscenter\/wp-content\/uploads\/2016\/11\/fea-hanan.jpg","datePublished":"2016-11-03T12:21:58+00:00","dateModified":"2025-11-19T12:59:48+00:00","author":{"@id":"https:\/\/www.rochester.edu\/newscenter\/#\/schema\/person\/e0d8d271cd290d592461fa9cefca013b"},"breadcrumb":{"@id":"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/#primaryimage","url":"https:\/\/www.rochester.edu\/newscenter\/wp-content\/uploads\/2016\/11\/fea-hanan.jpg","contentUrl":"https:\/\/www.rochester.edu\/newscenter\/wp-content\/uploads\/2016\/11\/fea-hanan.jpg","width":1000,"height":600,"caption":"PhD student Hanan Alwaseem, in the lab of Rudi Fasan, associate professor of chemistry, demonstrates how she produces analogs of a new compound the lab has developed as a potential treatment for acute myeloid leukemia. (University photo \/ Bob Marcotte)"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rochester.edu\/newscenter\/seed-grant-enables-researchers-to-try-new-approach-to-targeting-leukemia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rochester.edu\/newscenter\/"},{"@type":"ListItem","position":2,"name":"Seed grant enables researchers to try new approach to targeting leukemia"}]},{"@type":"WebSite","@id":"https:\/\/www.rochester.edu\/newscenter\/#website","url":"https:\/\/www.rochester.edu\/newscenter\/","name":"News Center","description":"Ä¢¹½´«Ã½","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rochester.edu\/newscenter\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.rochester.edu\/newscenter\/#\/schema\/person\/e0d8d271cd290d592461fa9cefca013b","name":"Bob Marcotte","url":"https:\/\/www.rochester.edu\/newscenter\/author\/bmarcotte\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rochester.edu\/newscenter\/wp-json\/wp\/v2\/posts\/192022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rochester.edu\/newscenter\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rochester.edu\/newscenter\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rochester.edu\/newscenter\/wp-json\/wp\/v2\/users\/286"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rochester.edu\/newscenter\/wp-json\/wp\/v2\/comments?post=192022"}],"version-history":[{"count":10,"href":"https:\/\/www.rochester.edu\/newscenter\/wp-json\/wp\/v2\/posts\/192022\/revisions"}],"predecessor-version":[{"id":196542,"href":"https:\/\/www.rochester.edu\/newscenter\/wp-json\/wp\/v2\/posts\/192022\/revisions\/196542"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rochester.edu\/newscenter\/wp-json\/wp\/v2\/media\/196522"}],"wp:attachment":[{"href":"https:\/\/www.rochester.edu\/newscenter\/wp-json\/wp\/v2\/media?parent=192022"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rochester.edu\/newscenter\/wp-json\/wp\/v2\/categories?post=192022"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rochester.edu\/newscenter\/wp-json\/wp\/v2\/tags?post=192022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}